InsidersTradesSigma
Track the Cantargia AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Cantargia AB has published 25 insider filings. Market capitalisation: €451.5m. The latest transaction was disclosed on 29 June 2026 (Purchase). Among the most active insiders: David Liberg. All data is accessible without an account.
25
Insider Decl.
n/a
Thresholds
€82,184
19 ops.
Buy Volume
n/a
n/a
Sell Volume
34Σ signal
Fundamental score
Ranked 5 of 29,024 companies
97.3
score / 100
Value97
Quality98
FCF yld29%
Earn yld28%
EV/EBITDA3.4x
ROE113%
Gross mgn·
Net mgn46%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 June 2026
Declarations25 total
14,012 shares@ SEK 2.250.0005% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029279090FI:csv-72bb636d19a2ab4034f4
63,054 shares0Teckningsrätt/UniträttISIN SE0029279082FI:csv-4daeba8f8c7e6a7ead38
4,444 shares@ SEK 2.250.0002% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029279090FI:csv-4e872d308724c063e973
82,071 shares0Teckningsrätt/UniträttISIN SE0029279082FI:csv-27550c86b989afa7bef3
18,238 shares@ SEK 2.250.0007% mcap43.0% of flowBTA (betald tecknad aktie)ISIN SE0029279090FI:csv-f97fa789846a229700c1
24,986 shares@ SEK 2.250.0009% mcap51.1% of flowBTA (betald tecknad aktie)ISIN SE0029279082FI:csv-f5436d02cf084c340bf7
33,400 shares@ SEK 2.250.0013% mcap51.1% of flowBTA (betald tecknad aktie)ISIN SE0029279082FI:csv-f29e73c163d13a287de2
99,999 shares0Teckningsrätt/UniträttISIN SE0029279082FI:csv-fefe5f54db24ca11980a
22,222 shares@ SEK 2.250.0008% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029279090FI:csv-30ded05acc959807358c
16,154 shares@ SEK 2.250.0006% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029279090FI:csv-91a701ea60e3a6b07b24
72,693 shares0Teckningsrätt/UniträttISIN SE0029279082FI:csv-e37572574e380fc12427
33,400 shares@ SEK 2.150.0012% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029279082FI:csv-950ff7d9da4992c21ba2
24,986 shares@ SEK 2.150.0009% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029279082FI:csv-f56980b571841841577c
16,666 shares@ SEK 2.250.0006% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029279090FI:csv-398a39a1d4a2b8ef5a98
74,997 shares0Teckningsrätt/UniträttISIN SE0029279082FI:csv-96a3874503e7fd35c431
35,866 shares@ SEK 2.250.0014% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029279090FI:csv-5a27b362748b543847ec
161,397 shares0Teckningsrätt/UniträttISIN SE0029279082FI:csv-ce4bdff3759c92b113c3
13,000 shares@ €0.37890.0006% mcap100.0% of flowAktieISIN SE0006371126FI:A003X340-1
1,000,000 shares0OptionFI:A003R943-1
250,000 shares0OptionFI:A003R861-1
250,000 shares0OptionFI:A003R856-1
250,000 shares0OptionFI:A003R851-1
1,471 shares@ €6.68100.0% of flowAktieISIN SE0006371126FI:A001P629-4
1,000 shares@ SEK 62.20100.0% of flowAktieISIN SE0006371126FI:A001P585-1
2,000 shares@ SEK 61.50100.0% of flowAktieISIN SE0006371126FI:A001P582-1
25 of 25 declarations
About Cantargia AB
Cantargia AB is a Swedish biopharmaceutical company focused on developing treatments for cancer and inflammatory diseases. It is listed on the Stockholm Stock Exchange (XSTO).